Pulmonary Hypertension in Interstitial Lung Diseases and Rare Interstitial Lung Diseases
    PDF
    Cite
    Share
    Request
    Invited Review
    P: 177-188
    April 2024

    Pulmonary Hypertension in Interstitial Lung Diseases and Rare Interstitial Lung Diseases

    Trd Sem 2024;12(1):177-188
    1. Etlik Şehir Hastanesi, Radyoloji Kliniği, Ankara, Türkiye
    No information available.
    No information available
    Received Date: 10.09.2023
    Accepted Date: 26.03.2024
    Publish Date: 02.05.2024
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Interstitial lung diseases (ILD), are associated with a high incidence of pulmonary hypertension (PH), which is linked with exercise limitation and a worse prognosis. Apart from Idiopathic pulmonary fibrosis, PH can occur in connective tissue diseases and sarcoidosis. Echocardiography and right heart catheterization are crucial modalities for the diagnosis of PH. Rare lung diseases are important pathologies that may create interstitial patterns in the lungs and should always be known and considered in the differential diagnosis of ILD.

    Keywords: Pulmonary hypertension, interstitial lung disease, lung fibrosis

    References

    1
    American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002; 165: 277-304. Erratum in: Am J Respir Crit Care Med 2002; 166: 426.
    2
    Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43: 3618-31. Erratum in: Eur Heart J 2023; 44: 1312.
    3
    Matsushita S, Matsuoka S, Yamashiro T, Fujikawa A, Yagihashi K, Kurihara Y, et al. Pulmonary arterial enlargement in patients with acute exacerbation of interstitial pneumonia. Clin Imaging 2014; 38: 454-7.
    4
    Caminati A, Cassandro R, Harari S. Pulmonary hypertension in chronic interstitial lung diseases. Eur Respir Rev 2013; 22: 292-301.
    5
    Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodeling, rarefaction or angiogenesis? J Anat 2002; 201: 335-48.
    6
    Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393-9.
    7
    Grosse C, Grosse A. CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 2010; 30: 1753-77.
    8
    Masy M, Giordano J, Petyt G, Hossein-Foucher C, Duhamel A, Kyheng M, et al. Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2018; 28: 5100-10.
    9
    Wells A. CT detection of pulmonary hypertension in interstitial lung disease: the glass is half full. Radiology; 260: 628-31.
    10
    Charbeneau RP, Peters-Golden M. Eicosanoids: mediators and therapeutic targets in fibrotic lung disease. Clin Sci (Lond) 2005; 108: 479-91.
    11
    Handa T, Nagai S, Miki S, Fushimi Y, Ohta K, Mishima M, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006; 129: 1246-52.
    12
    Damuth TE, Bower JS, Cho K, Dantzker DR. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 1980; 78: 888-91.
    13
    Hallowell RW, Reed RM, Fraig M, Horton MR, Girgis RE. Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia. Pulm Circ 2012; 2: 101-6.
    14
    Walkoff L, White DB, Chung JH, Asante D, Cox CW. the four corners sign: a specific imaging feature in differentiating systemic sclerosis-related interstitial lung disease from idiopathic pulmonary fibrosis. J Thorac Imaging 2018; 33: 197-203.
    15
    Simonson JS, Schiller NB, Petri M, Hellmann DB. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989; 16: 918-25.
    16
    Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007; 86: 299-315.
    17
    Holbert JM, Costello P, Li W, Hoffman RM, Rogers RM. CT features of pulmonary alveolar proteinosis. AJR Am J Roentgenol 2001; 176: 1287-94.
    18
    Shamburek RD, Brewer HB Jr, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 2001; 321: 66-75.
    19
    Agarwal PP, Gross BH, Holloway BJ, Seely J, Stark P, Kazerooni EA. Thoracic CT findings in Birt-Hogg-Dube syndrome. AJR Am J Roentgenol 2011; 196: 349-52.
    2024 ©️ Galenos Publishing House